On the fifth anniversary of Obamacare's passage, the head of the prestigious Cleveland Clinic says he sees some positive change.» Read More
Humana said the government's proposed 2014 payment rates for Medicare participants were lower than expected and would affect its profit outlook, and its shares fell in premarket trading.
A sharp and surprisingly persistent slowdown in the growth of health care costs is helping to narrow the federal deficit, leaving budget experts trying to figure out whether the trend will last.
A new report shows non-network providers are charging insured patients outrageous out-of-network fees. Doctors fault insurers for reimbursing doctors at far lower rates than before.
Flu season is drawing attention to mandatory paid sick leave for the 40 percent of American private-sector workers — more than 40 million people — who don't have it.
Rock bottom interest rates will likely boost key stocks in the biotechnology sector, but Obamacare will dampen prospects for HMO shares.
DaVita could be a beneficiary among health care stocks from changes in the U.S. health care market, an analyst said Wednesday.
Some small businesses are rethinking their business models to address the new federal health-care law.
A provision of the Affordable Care Act squeezes premiums that drugmakers collect from the government has yielded savings of $687 million in the first six months of 2012.
Insurers, hospitals and doctors say they are forming partnerships and creating programs to find ways to slow the growth in the nation’s $2.7 trillion health care bill. The New York Times reports.
The growth of health spending has slowed substantially in the last few years, surprising experts and offering some fuel for optimism about the federal government’s long-term fiscal health. The New York Times reports.
If you're worried about how yours might fare during a downturn, consider a recession-proof industry, which caters to ongoing demands.
Expecting Aetna and UnitedHealth to beat Wall Street estimates as health insurers kick off fourth-quarter earnings, senior analyst Peter Costa of Wells Fargo says these companies will continue their winning streak in 2012, due to rising costs, lower unemployment and even health-care reform.
Dr. Tony Coles, president & CEO of Onyx Pharmaceuticals, discusses his outlook on pharma in the new year. Biotech stocks were up 7% in 2011. "The emerging markets should be great for us," he adds.
While some believe government intervention in health-care reform is the only way forward, there are already health-care organizations around the country that can deliver better quality care at a lower cost.
Is legislated healthcare reform here to stay? As we watch the presidential race heat up – and look to a Supreme Court ruling this summer — no one knows for sure. Regardless, we as a nation need to realize that traditional thinking around healthcare is forever changed.
Traditionally, managed-care stocks have performed better in the fourth quarter as investors get pricing visibility for the coming year, one portfolio manager said.
JPMorgan says education services, electronic equipment and instruments, as well as aerospace and defense could be the hardest-hit sectors, as the bipartisan congressional “supercommittee” looks for targets to cut the federal budget.
While some people are frustrated about the long wait times for doctors appointments, some believe doctors are doing their jobs.
$1 million isn’t what it used to be, in part because a lot of people don’t know how far it can go, and the amount of time and effort that it would take to spend it.
For the first time in its history, Medicare will soon track spending on millions of individual beneficiaries, reward hospitals that hold down costs and penalize those whose patients prove most expensive. The New York Times reports.